Prospects of transplantation in human neurodegenerative diseases
Identifieur interne : 000E53 ( Main/Corpus ); précédent : 000E52; suivant : 000E54Prospects of transplantation in human neurodegenerative diseases
Auteurs : Olle LindvallSource :
- Trends in Neurosciences [ 0166-2236 ] ; 1991.
Abstract
Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.
Url:
DOI: 10.1016/0166-2236(91)90167-S
Links to Exploration step
ISTEX:4685E4A536780FE241883C727BC431FB3706FACFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Prospects of transplantation in human neurodegenerative diseases</title><author><name sortKey="Lindvall, Olle" sort="Lindvall, Olle" uniqKey="Lindvall O" first="Olle" last="Lindvall">Olle Lindvall</name><affiliation><mods:affiliation>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4685E4A536780FE241883C727BC431FB3706FACF</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1016/0166-2236(91)90167-S</idno><idno type="url">https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000E53</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Prospects of transplantation in human neurodegenerative diseases</title><author><name sortKey="Lindvall, Olle" sort="Lindvall, Olle" uniqKey="Lindvall O" first="Olle" last="Lindvall">Olle Lindvall</name><affiliation><mods:affiliation>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Trends in Neurosciences</title><title level="j" type="abbrev">TINS</title><idno type="ISSN">0166-2236</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991">1991</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="376">376</biblScope><biblScope unit="page" to="384">384</biblScope></imprint><idno type="ISSN">0166-2236</idno></series><idno type="istex">4685E4A536780FE241883C727BC431FB3706FACF</idno><idno type="DOI">10.1016/0166-2236(91)90167-S</idno><idno type="PII">0166-2236(91)90167-S</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0166-2236</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Olle Lindvall</name><affiliations><json:string>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</json:string></affiliations></json:item></author><language><json:string>eng</json:string></language><abstract>Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.</abstract><qualityIndicators><score>7.396</score><pdfVersion>1.4</pdfVersion><pdfPageSize>591 x 816 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1083</abstractCharCount><pdfWordCount>6995</pdfWordCount><pdfCharCount>44542</pdfCharCount><pdfPageCount>9</pdfPageCount><abstractWordCount>158</abstractWordCount></qualityIndicators><title>Prospects of transplantation in human neurodegenerative diseases</title><pii><json:string>0166-2236(91)90167-S</json:string></pii><genre><json:string>review-article</json:string></genre><host><volume>14</volume><pii><json:string>S0166-2236(00)X0168-3</json:string></pii><pages><last>384</last><first>376</first></pages><issn><json:string>0166-2236</json:string></issn><issue>8</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Trends in Neurosciences</title><publicationDate>1991</publicationDate></host><categories><wos><json:string>NEUROSCIENCES</json:string></wos></categories><publicationDate>1991</publicationDate><copyrightDate>1991</copyrightDate><doi><json:string>10.1016/0166-2236(91)90167-S</json:string></doi><id>4685E4A536780FE241883C727BC431FB3706FACF</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Prospects of transplantation in human neurodegenerative diseases</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1991</date></publicationStmt><notesStmt><note type="content">Section title: Review</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Prospects of transplantation in human neurodegenerative diseases</title><author><persName><forename type="first">Olle</forename><surname>Lindvall</surname></persName><affiliation>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</affiliation></author></analytic><monogr><title level="j">Trends in Neurosciences</title><title level="j" type="abbrev">TINS</title><idno type="pISSN">0166-2236</idno><idno type="PII">S0166-2236(00)X0168-3</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991"></date><biblScope unit="volume">14</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="376">376</biblScope><biblScope unit="page" to="384">384</biblScope></imprint></monogr><idno type="istex">4685E4A536780FE241883C727BC431FB3706FACF</idno><idno type="DOI">10.1016/0166-2236(91)90167-S</idno><idno type="PII">0166-2236(91)90167-S</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.</p></abstract></profileDesc><revisionDesc><change when="1991">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="rev"><item-info><jid>TINS</jid><aid>9190167S</aid><ce:pii>0166-2236(91)90167-S</ce:pii><ce:doi>10.1016/0166-2236(91)90167-S</ce:doi><ce:copyright type="unknown" year="1991"></ce:copyright></item-info><head><ce:dochead><ce:textfn>Review</ce:textfn></ce:dochead><ce:title>Prospects of transplantation in human neurodegenerative diseases</ce:title><ce:author-group><ce:author><ce:given-name>Olle</ce:given-name><ce:surname>Lindvall</ce:surname></ce:author><ce:affiliation><ce:textfn>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</ce:textfn></ce:affiliation></ce:author-group><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.</ce:simple-para></ce:abstract-sec></ce:abstract></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Prospects of transplantation in human neurodegenerative diseases</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Prospects of transplantation in human neurodegenerative diseases</title></titleInfo><name type="personal"><namePart type="given">Olle</namePart><namePart type="family">Lindvall</namePart><affiliation>Restorative Neurology Unit, Dept of Neurology, University Hospital, S-22185 Lund, Sweden.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="Review article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1991</dateIssued><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Over the past decade experimental data obtained from animals have suggested that restoration or preservation of function through cell transplantation into the CNS might be developed into a useful therapeutic approach in human neurodegenerative disorders. Clinical trials in patients with Parkinson's disease have provided evidence that grafts of fetal dopaminergic neurons can survive and induce functional effects in the human brain, but no treatment based on transplantation is available yet. Initiation of studies of patients with striatal neural grafts in Huntington's disease is supported by findings in animal models, and is motivated by the lack of therapy and the severity of the symptoms in this disorder. Application of cell transplantation to other neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and hereditary ataxia is definitely premature. Further progress can be made only by systematic studies in animals of the scientific issues that can now be defined, but will also require clinical trials in a few well-monitored patients.</abstract><note type="content">Section title: Review</note><relatedItem type="host"><titleInfo><title>Trends in Neurosciences</title></titleInfo><titleInfo type="abbreviated"><title>TINS</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">199108</dateIssued></originInfo><identifier type="ISSN">0166-2236</identifier><identifier type="PII">S0166-2236(00)X0168-3</identifier><part><date>199108</date><detail type="volume"><number>14</number><caption>vol.</caption></detail><detail type="issue"><number>8</number><caption>no.</caption></detail><extent unit="issue pages"><start>319</start><end>388</end></extent><extent unit="pages"><start>376</start><end>384</end></extent></part></relatedItem><identifier type="istex">4685E4A536780FE241883C727BC431FB3706FACF</identifier><identifier type="DOI">10.1016/0166-2236(91)90167-S</identifier><identifier type="PII">0166-2236(91)90167-S</identifier><recordInfo><recordContentSource>ELSEVIER</recordContentSource></recordInfo></mods></metadata><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/4685E4A536780FE241883C727BC431FB3706FACF/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">NEUROSCIENCES</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:4685E4A536780FE241883C727BC431FB3706FACF
|texte= Prospects of transplantation in human neurodegenerative diseases
}}
| This area was generated with Dilib version V0.6.23. |  |